HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $570 Price Target

Benzinga · 09/02/2025 16:14
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $570 price target.